FDA inspected Indian cold medicine detected contaminants prohibited in food There is no registration of such medicinal products in Thailand. and can’t find any sales information on the internet with strict regulatory measures for products sold in the country and continue to monitor
On October 20, 2022 Dr. Surajok Thangwiwat, Deputy Secretary-General of the Food and Drug Administration Revealed that if there is news that a child in Indonesia has acute renal failure After taking paracetamol syrup made in India which recently The World Health Organization has issued a warning to remove four of Maiden Pharmaceuticals’ anti-cold products. The products produced in India were 1. Promethazine oral solution BP 2. Kofexmalin baby cough syrup 3. Makoff baby cough syrup and 4. Magrip N cold syrup. Diethylene glycol contamination was detected. ) and ethylene glycol, which can affect the kidneys, leading to the deaths of 70 children in the Gambia, the Food and Drug Administration (FDA) has reviewed. No registration of the said medicinal product was found. And can’t find sales information on the Internet of Thailand. Including no import of finished pharmaceutical products and raw materials from Maiden Co., Ltd.
Such contaminants are classified as prohibited items in food. This results in bodily harm such as abdominal pain, vomiting, diarrhea, urinary incontinence, headaches, mental disorders. Kidney failure and possibly death. However, the FDA has strict regulatory measures for products sold in the country. and will continue to monitor
* can follow And share Hfocus news at https://www.facebook.com/Hfocus.org